Zoledronic Acid Injection (Komigu) 5?mg Low price wholesale comparison

Zoledronic Acid Injection (Komigu) 5?mg Low price wholesale comparison

$2.00

Komigu is a research-grade zoledronic acid (5?mg/100?mL) ready-to-use infusion bag. Manufactured by Sichuan Kelun Pharmaceutical Co., Ltd., NMPA-approved under H20183157. Ideal for bone-resorption and osteoclast activity studies. Not for therapeutic use.?Please consult staff for other specifications and uses?

EMI starting from $0.00/month - View Plans

Description

Zoledronic acid is a potent bisphosphonate that inhibits osteoclast-mediated bone resorption by targeting farnesyl pyrophosphate synthase. It has been shown to significantly increase bone mineral density in Chinese populations, demonstrating clinical effectiveness equivalent to branded formulations. This research-grade infusion contains 5?mg zoledronic acid in 100?mL of ready-to-use solution, manufactured in sterile conditions.

Packaged in a polypropylene infusion bag, Komigu is manufactured by Sichuan Kelun Pharmaceutical Co., Ltd. and approved for research applications under China’s NMPA licence number H20183157, drug code 86902180002082.

Strictly for laboratory research purposes—not for therapeutic, veterinary, or diagnostic use.


Zoledronic Acid Injection Product Specifications

ParameterDetails
Product NameZoledronic Acid Injection (Komigu)
Generic NameZoledronic Acid
CAS Number165800?06?6
Molecular FormulaC?H??N?O?P?·H?O
Molecular Weight290.1?g/mol
Dosage FormIntravenous infusion bag
Strength5?mg zoledronic acid in 100?mL solution
Packaging UnitSingle-use infusion bag
Approval NumberH20183157 (China NMPA)
Drug Product Code86902180002082
ManufacturerSichuan Kelun Pharmaceutical Co., Ltd.
Intended UseLaboratory research
Storage ConditionsStore at 20–25?°C; stable at controlled room temperature

Zoledronic Acid Injection Mechanism & Research Applications

Zoledronic acid targets osteoclasts to inhibit bone breakdown by binding to bone mineral surfaces. It has shown effectiveness in increasing bone density and reducing biomarkers of bone resorption in human trials.
Common laboratory research applications include:

  • Osteoclast activity assays

  • Bone resorption and mineralization models

  • In vitro and in vivo bone metabolism studies

  • Comparative testing against other bisphosphonates

  • Biomarker analysis for bone turnover (e.g., ?-CTX, P1NP)


Zoledronic Acid Injection Safety & Handling

  • Use Restriction: For laboratory research only. Not approved for clinical or veterinary use.

  • Handling: Wear gloves and lab coat; ensure aseptic infusion technique.

  • Storage: Store sealed at 20–25?°C; protect from freezing and extreme heat.

  • Disposal: Dispose of unused solution and container per local biosafety protocols.


Core Keywords

Zoledronic acid injection, Komigu zoledronate, 5?mg bisphosphonate infusion, bone resorption research reagent, osteoclast inhibitor injection, laboratory zoledronic acid bag, NMPA H20183157 zoledronic acid, wholesale research bisphosphonate, Sichuan Kelun zoledronic acid


Research Use Disclaimer

This product is for laboratory research use only and not approved for clinical, diagnostic, or veterinary applications. Misuse may present health or regulatory risks. Always adhere to institutional and local biosafety standards.

Additional information

Weight1 kg
Dimensions26 × 23 × 28 cm

Reviews

There are no reviews yet.

Be the first to review “Zoledronic Acid Injection (Komigu) 5?mg Low price wholesale comparison”

Your email address will not be published. Required fields are marked *

Q1: Can I use this injection clinically or in animals?

A1: No. It is strictly for research purposes and is not approved for therapeutic or diagnostic use.

Q2: Do you accept bulk orders?

A2: Yes. We support both wholesale and retail orders, with options for international shipping.

Q3: Are COA and SDS documents available?

A3: Yes—Certificate of Analysis and Safety Data Sheet are available upon request.

Q4: What makes zoledronic acid useful in research?

A4: It inhibits osteoclast activity and bone resorption, making it ideal for studies on bone health and metabolic regulation.

Q5: Is there any evidence of its efficacy?

A5: Yes—studies have demonstrated significant bone density improvement with generic zoledronic acid formulations comparable to branded versions


EMI Options